AHCO PE Ratio & Valuation,Is AHCO Overvalued

AHCO Relative Valuation

AHCO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, AHCO is overvalued; if below, it's undervalued.

Historical Valuation

Adapthealth Corp (AHCO) is now in the Fair zone, suggesting that its current forward PE ratio of 11.97 is considered Fairly compared with the five-year average of 14.45. The fair price of Adapthealth Corp (AHCO) is between 7.92 to 15.76 according to relative valuation methord.

Relative Value

Fair Zone

7.92-15.76

Current Price：10.27

Fair

12.05

4.68

EV/EBITDA

Adapthealth Corp. (AHCO) has a current EV/EBITDA of 4.68. The 5-year average EV/EBITDA is 6.17. The thresholds are as follows: Strongly Undervalued below 3.49, Undervalued between 3.49 and 4.83, Fairly Valued between 7.51 and 4.83, Overvalued between 7.51 and 8.85, and Strongly Overvalued above 8.85. The current Forward EV/EBITDA of 4.68 falls within the Undervalued range.

12.05

EV/EBIT

Adapthealth Corp. (AHCO) has a current EV/EBIT of 12.05. The 5-year average EV/EBIT is 13.35. The thresholds are as follows: Strongly Undervalued below 8.78, Undervalued between 8.78 and 11.07, Fairly Valued between 15.64 and 11.07, Overvalued between 15.64 and 17.92, and Strongly Overvalued above 17.92. The current Forward EV/EBIT of 12.05 falls within the Historic Trend Line -Fairly Valued range.

0.41

Adapthealth Corp. (AHCO) has a current PS of 0.41. The 5-year average PS is 0.69. The thresholds are as follows: Strongly Undervalued below -0.06, Undervalued between -0.06 and 0.31, Fairly Valued between 1.07 and 0.31, Overvalued between 1.07 and 1.45, and Strongly Overvalued above 1.45. The current Forward PS of 0.41 falls within the Historic Trend Line -Fairly Valued range.

2.50

P/OCF

Adapthealth Corp. (AHCO) has a current P/OCF of 2.50. The 5-year average P/OCF is 4.38. The thresholds are as follows: Strongly Undervalued below -0.35, Undervalued between -0.35 and 2.01, Fairly Valued between 6.74 and 2.01, Overvalued between 6.74 and 9.11, and Strongly Overvalued above 9.11. The current Forward P/OCF of 2.50 falls within the Historic Trend Line -Fairly Valued range.

7.24

P/FCF

Adapthealth Corp. (AHCO) has a current P/FCF of 7.24. The 5-year average P/FCF is 13.03. The thresholds are as follows: Strongly Undervalued below -3.83, Undervalued between -3.83 and 4.60, Fairly Valued between 21.46 and 4.60, Overvalued between 21.46 and 29.89, and Strongly Overvalued above 29.89. The current Forward P/FCF of 7.24 falls within the Historic Trend Line -Fairly Valued range.

Adapthealth Corp (AHCO) has a current Price-to-Book (P/B) ratio of 0.84. Compared to its 3-year average P/B ratio of 0.82 , the current P/B ratio is approximately 2.65% higher. Relative to its 5-year average P/B ratio of 1.40, the current P/B ratio is about -39.96% higher. Adapthealth Corp (AHCO) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 10.39%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 7.41% , the current FCF yield is about -100.00% lower.

0.85

P/B

Median3y

0.82

Median5y

1.40

15.67

FCF Yield

Median3y

10.39

Median5y

7.41

Competitors Valuation Multiple

The average P/S ratio for AHCO's competitors is , providing a benchmark for relative valuation. Adapthealth Corp Corp (AHCO) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 1.79%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of AHCO increased by 8.72% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 2.97 to 3.14.

The secondary factor is the Revenue Growth, contributed 1.79%to the performance.

Overall, the performance of AHCO in the past 1 year is driven by Margin Expansion. Which is more sustainable.

1.79%

805.86M → 820.31M

Revenue Growth

5.72%

2.97 → 3.14

Margin Expansion

1.21%

18.68 → 18.90

P/E Change

8.72%

9.52 → 10.35

Mkt Cap Growth

People Also Watch

Frequently Asked Questions

Is Adapthealth Corp (AHCO) currently overvalued or undervalued?

What is Adapthealth Corp (AHCO) fair value?

AHCO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Adapthealth Corp (AHCO) is between 7.92 to 15.76 according to relative valuation methord.

How does AHCO's valuation metrics compare to the industry average?

What is the current P/B ratio for Adapthealth Corp (AHCO) as of Dec 17 2025?

As of Dec 17 2025, Adapthealth Corp (AHCO) has a P/B ratio of 0.84. This indicates that the market values AHCO at 0.84 times its book value.

What is the current FCF Yield for Adapthealth Corp (AHCO) as of Dec 17 2025?

As of Dec 17 2025, Adapthealth Corp (AHCO) has a FCF Yield of 0.00%. This means that for every dollar of Adapthealth Corp’s market capitalization, the company generates 0.00 cents in free cash flow.

What is the current Forward P/E ratio for Adapthealth Corp (AHCO) as of Dec 17 2025?

As of Dec 17 2025, Adapthealth Corp (AHCO) has a Forward P/E ratio of 11.97. This means the market is willing to pay $11.97 for every dollar of Adapthealth Corp’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Adapthealth Corp (AHCO) as of Dec 17 2025?

As of Dec 17 2025, Adapthealth Corp (AHCO) has a Forward P/S ratio of 0.00. This means the market is valuing AHCO at $0.00 for every dollar of expected revenue over the next 12 months.

AHCO Valuation